Metabolic & Cardiometabolic
Part of Biotech - Drug Development
 LLY | Eli Lilly & Co. | $1.0t | $1191.00 | +1.8% | 2.3M |
 AZN | AstraZeneca PLC | $263.1b | $161.34 | -0.1% | 2.2M |
 MDGL | Madrigal Pharmaceuticals, Inc. Common Stock | $11.1b | $511.50 | -0.8% | 269.6K |
 PTGX | Protagonist Therapeutics, Inc | $8.5b | $143.35 | +6.6% | 681.2K |
 TERN | Terns Pharmaceuticals, Inc. Common Stock | $6.1b | $52.97 | +0.0% | 2.3M |
 KNSA | Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares | $5.8b | $77.79 | -2.0% | 301.7K |
 TVTX | Travere Therapeutics, Inc. Common Stock | $5.1b | $62.54 | -0.5% | 2.3M |
 VKTX | Viking Therapeutics, Inc | $3.8b | $33.50 | -0.6% | 1.0M |
 NAMS | NewAmsterdam Pharma Company N.V. Ordinary Shares | $3.2b | $28.79 | +0.9% | 1.5M |
 MBX | MBX Biosciences, Inc. Common Stock | $3.1b | $67.09 | -0.7% | 454.8K |
 MLYS | Mineralys Therapeutics, Inc. Common Stock | $2.3b | $26.99 | +0.6% | 355.8K |
 SEPN | Septerna, Inc. Common Stock | $1.6b | $39.78 | +2.1% | 161.8K |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.5b | $28.53 | +2.6% | 135.4K |
 MNKD | Mannkind Corporation | $1.2b | $3.85 | -5.2% | 8.7M |
 LXRX | Lexicon Pharmaceuticals, Inc. | $1.0b | $2.35 | -3.9% | 4.5M |
 ESPR | Esperion Therapeutics, Inc. | $0.8b | $3.19 | 0.0% | N/A |
 GYRE | Gyre Therapeutics, Inc. Common Stock | $0.6b | $6.41 | +3.9% | 34.9K |
 ALT | Altimmune, Inc. Common Stock | $0.6b | $3.02 | -0.8% | 3.6M |
 TENX | Tenax Therapeutics, Inc. | $0.5b | $13.34 | +1.8% | 1.1M |
 RZLT | Rezolute, Inc. Common Stock (NV) | $472.8m | $4.70 | +0.2% | 819.9K |
 SGMT | Sagimet Biosciences Inc. Series A Common Stock | $441.5m | $8.64 | +1.2% | 1.4M |
 BIOA | BioAge Labs, Inc. Common Stock | $401.9m | $11.30 | +2.2% | 737.1K |
 ORMP | Oramed Pharmaceuticals Inc. | $179.7m | $4.30 | -0.5% | 146.4K |
 CRDL | Cardiol Therapeutics Inc. Class A Common Shares | $146.4m | $1.38 | +1.9% | 702.5K |
 AARD | Aardvark Therapeutics, Inc. Common Stock | $144.4m | $7.33 | -4.1% | 58.8K |
 MIST | Milestone Pharmaceuticals Inc. Common Shares | $139.4m | $1.16 | +1.3% | 569.9K |
 VTVT | vTv Therapeutics Inc. Class A Common Stock | $127.6m | $34.51 | +0.5% | 120.9K |
 VANI | Vivani Medical, Inc. Common Stock (DE) | $114.7m | $1.39 | -0.7% | 48.0K |
 GUTS | Fractyl Health, Inc. Common Stock | $108.7m | $0.70 | +0.5% | 730.3K |
 BMEA | Biomea Fusion, Inc. Common Stock | $84.6m | $1.25 | -0.8% | 416.2K |
 VERU | Veru Inc. | $36.3m | $2.28 | -1.3% | 230.3K |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $26.2m | $5.27 | +17.3% | 262.0K |
 SKYE | Skye Bioscience, Inc. Common Stock | $20.5m | $0.47 | -13.5% | 368.3K |
 GRDX | GridAI Technologies Corp. Common Stock | $20.4m | $2.88 | -0.4% | 37.9K |
 NCEL | NewcelX Ltd. Ordinary Shares | $18.4m | $3.13 | 0.0% | 20.4K |
 LPCN | Lipocine Inc. | $17.5m | $2.16 | -1.8% | 31.2K |
 MTVA | MetaVia Inc. Common Stock | $7.6m | $1.45 | -1.3% | 34.0K |
 CVKD | Cadrenal Therapeutics, Inc. Common Stock | $6.2m | $2.01 | -2.0% | 23.4K |
 CURX | Curanex Pharmaceuticals Inc Common Stock | $5.8m | $0.19 | 0.0% | 29.1K |
 GLMD | Galmed Pharmaceuticals Ltd. | $5.1m | $0.55 | -2.0% | 12.8K |
 TCRT | Alaunos Therapeutics, Inc. Common Stock | $4.7m | $2.00 | -1.5% | 4.0K |
 ELAB | PMGC Holdings Inc. Common Stock | $4.2m | $0.95 | -3.0% | 105.6K |